CRWM
TMO icon

Castle Rock Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Castle Rock Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$806K Sell
1,228
-2,826
-70% -$1.68M 0.15% 132
2026
Q2 		$2.08M Buy
4,054
+353
+10% +$169K 0.41% 74
2026
Q1 		$1.82M Buy
3,701
+34
+0.9% +$18.5K 0.39% 75
2025
Q4 		$2.09M Buy
3,667
+76
+2% +$43K 0.45% 65
2025
Q3 		$1.88M Buy
3,591
+46
+1% +$21.4K 0.42% 66
2025
Q2 		$1.46M Buy
3,545
+347
+11% +$145K 0.34% 85
2025
Q1 		$1.56M Sell
3,198
-131
-4% -$70.9K 0.42% 62
2024
Q4 		$1.77M Buy
3,329
+167
+5% +$91.8K 0.42% 64
2024
Q3 		$1.89M Buy
3,162
+57
+2% +$33.7K 0.45% 60
2024
Q2 		$1.68M Buy
3,105
+115
+4% +$65.9K 0.42% 65
2024
Q1 		$1.72M Buy
2,990
+1,189
+66% +$667K 0.47% 56
2023
Q4 		$956K Buy
1,801
+161
+10% +$77.9K 0.29% 95
2023
Q3 		$819K Buy
1,640
+43
+3% +$22.9K 0.28% 91
2023
Q2 		$831K Buy
1,597
+66
+4% +$35.6K 0.28% 85
2023
Q1 		$819K Buy
1,531
+22
+1% +$12.4K 0.29% 73
2022
Q4 		$871K Buy
1,509
+30
+2% +$15.9K 0.39% 65
2022
Q3 		$741K Sell
1,479
-18
-1% -$10.1K 0.37% 69
2022
Q2 		$829K Sell
1,497
-284
-16% -$156K 0.42% 57
2022
Q1 		$1.02M Sell
1,781
-1,651
-48% -$948K 0.47% 50
2021
Q4 		$1.99M Sell
3,432
-22
-0.6% -$13.7K 0.81% 32
2021
Q3 		$2.16M Buy
3,454
+191
+6% +$105K 0.74% 33
2021
Q2 		$1.76M Buy
3,263
+364
+13% +$172K 0.65% 39
2021
Q1 		$1.4M Buy
2,899
+244
+9% +$116K 0.57% 57
2020
Q4 		$1.37M Buy
2,655
+298
+13% +$140K 0.57% 50
2020
Q3 		$1.1M Buy
2,357
+1,067
+83% +$441K 0.72% 44
2020
Q2 		$536K Buy
+1,290
New +$432K 0.31% 110
2020
Q1 		– Sell
-4,130
Closed -$1.4M – 183
2019
Q4 		$1.4M Buy
+4,130
New +$1.25M 1.26% 13
2019
Q3 		– Sell
-800
Closed -$236K – 189
2019
Q2 		$236K Buy
+800
New +$220K 0.26% 118

Other funds holding TMO

SP
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Castle Rock Wealth Management's TMO Position: Q3 2026 in Review

Castle Rock Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 70% in Q3 2026, selling an estimated $1.68M and leaving 1,228 shares worth $806K. The position accounts for 0.15% of the portfolio, ranked #132.

Castle Rock Wealth Management first reported a position in TMO in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.16M in Q3 2021. 302 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Castle Rock Wealth Management held 1,228 shares of Thermo Fisher Scientific worth $806K as of Q3 2026.
  • Castle Rock Wealth Management sold 2,826 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.68M.
  • Thermo Fisher Scientific made up 0.15% of Castle Rock Wealth Management's portfolio in Q3 2026, its #132 holding.
  • Castle Rock Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 28 quarters since.
  • Castle Rock Wealth Management's Thermo Fisher Scientific position peaked at $2.16M in Q3 2021.
  • 302 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Castle Rock Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.